IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Bryo-Pharmaceuticals: An Emerging Era of Pharmaceutical Products

Bryo-Pharmaceuticals: An Emerging Era of Pharmaceutical Products
View Sample PDF
Author(s): Saumya Pandey (School of Agriculture, Uttaranchal University, India)and Afroz Alam (Department of Bioscience and Biotechnology, Banasthali Vidyapith, India)
Copyright: 2020
Pages: 16
Source title: Advanced Pharmacological Uses of Medicinal Plants and Natural Products
Source Author(s)/Editor(s): Ajeet Singh (National Dairy Research Institute, India), Padam Singh (Vaccine and Infectious Disease Research Centre, Translational Health Science and Technology Institute, India)and Navneet Bithel (Gurukul Kangri University, India)
DOI: 10.4018/978-1-7998-2094-9.ch014

Purchase

View Bryo-Pharmaceuticals: An Emerging Era of Pharmaceutical Products on the publisher's website for pricing and purchasing information.

Abstract

Because bryophytes are a promising source of a large number of secondary metabolites, they are used efficiently in surgical dressing, herbal medicines, antibiotics, and other pharmaceutical products. The advent of several biotechnological tools and their utilization in the exploitation of pharmaceuticals properties of bryophytes leads to a new era of bryo-pharmaceuticals. Nowadays, the biopharmaceutical productions using moss system are gaining importance over other plant systems because of their unique properties such as predominant haploid gametophytic stage, stable gene integration, efficient secretary signals, and large-scale production in bioreactors. Several researchers have established moss system as safe and efficient for the production of several complex modified recombinant pharmaceuticals under standard conditions. The moss Physcomitrella patens are extensively exploited and commercialized as a production host for production of several recombinant proteins, human growth factors, antibiotics, and its derivatives.

Related Content

Abul Kalam Azad, Mohamad Dayoob, Fatema Tuz Zohera. © 2024. 21 pages.
W. H. P. A. D. Perera, Mithuni N. Senadeera, Dinusha N. Udukala. © 2024. 26 pages.
Thi Van Anh Nguyen, Trang Nguyen Ngoc, Thanh Tung Bui. © 2024. 43 pages.
Abul Kalam Azad, Mallari Praveen, Wan Mohd Azizi Bin Wan Sulaiman. © 2024. 31 pages.
Bancha Yingngam. © 2024. 43 pages.
Babi Lakkoju, Swapna Asuthkar, Gundla Rambabu, Kolli Balakrishna. © 2024. 20 pages.
Arthi Gunasekaran, Trisha Sathya, Vijaya Anand Arumugam, Balamuralikrishnan Balasubramanian, Asirvatham Alwin Robert, Arun Meyyazhagan. © 2024. 31 pages.
Body Bottom